This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Bisphosphonate-associated Osteonecrosis Of The Jaw
Information about Bisphosphonate-associated Osteonecrosis Of The Jaw: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Bisphosphonate-associated Osteonecrosis Of The Jaw
Most recent studies have shown that Bisphosphonate-associated Osteonecrosis Of The Jaw shares some biological mechanisms with bisphosphonate-associated-osteonecrosis, bone-diseases, bone-necrosis, bone-neoplasms, fracture, jaw-diseases, malignant-neoplasm-of-breast, malignant-neoplasm-of-prostate, malignant-neoplasms, mammary-neoplasms, mandibular-diseases, maxillary-diseases, metastatic-malignant-neoplasm-to-the-bone, multiple-myeloma, neoplasm-metastasis, neoplasms, oral-bisphosphonates-causing-adverse-effects-in-therapeutic-use, osteoporosis, pain.
Among the many pathways, these few ones have gauged particular interests from scientists studying Bisphosphonate-associated Osteonecrosis Of The Jaw, and have been seen in publications frequently: Aging, Angiogenesis, Bone Remodeling, Bone Resorption, Cell Migration, Cell Proliferation, Chemotaxis, Dehiscence, Endothelial Cell Proliferation, Localization, Ossification, Osteoclast Differentiation, Pathogenesis, Programmed Cell Death, Regeneration, Secretion, Tissue Regeneration, Transport, Vasculogenesis, Wound Healing
Quite a number of genes have been found to play important roles in Bisphosphonate-associated Osteonecrosis Of The Jaw, such as ABCB6, BGLAP, C4BPA, CARD14, CYP19A1, CYP27A1, CYP2C8, ESR1, FDPS, FGF7, GGPS1, PRDX2, PRNP, PTH, PTRH1, TNFRSF11A, TNFRSF11B, TNFSF11, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.